Capecitabine is an effective treatment in gemcitabine-refractory advanced pancreatic cancer

被引：0
|
作者：
Arrazubi, V [1 ]
Illarramendi, J. [1 ]
Lainez, N. [1 ]
Salgado, E. [1 ]
Martinez, M. [1 ]
Amillano, K. [1 ]
Vera, R. [1 ]
机构：
[1] Hosp Navarra, Pamplona, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [1] Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer
    Kulke, Matthew H.
    Blaszkowsky, Lawrence S.
    Ryan, David P.
    Clark, Jeffrey W.
    Meyerhardt, Jeffrey A.
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kwak, Eunice L.
    Muzikansky, Alona
    Lawrence, Colleen
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4787 - 4792
  • [2] Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
    Nature Clinical Practice Oncology, 2007, 4 (9): : 504 - 504
  • [3] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Park, Se Jun
    Kim, Hyunho
    Shin, Kabsoo
    Lee, Myung Ah
    Hong, Tae Ho
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (11) : 1021 - 1030
  • [4] Updates on Treatment of Gemcitabine-Refractory Pancreatic Adenocarcinoma
    Makrilia, Nektaria
    Syrigos, Kostas N.
    Saif, Muhammad W.
    JOURNAL OF THE PANCREAS, 2011, 12 (04): : 351 - 354
  • [5] Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
    Kim, Jung Hoon
    Lee, Sang-Cheol
    Oh, Sung Yong
    Song, Seo-Young
    Lee, Namsu
    Nam, Eun Mi
    Lee, Soonil
    Hwang, In Gyu
    Lee, Hyo Rak
    Lee, Kyu Taek
    Bae, Sang-Byung
    Kim, Han Jo
    Jang, Joung Soon
    Lim, Do Hyoung
    Lee, Hyun Woo
    Kang, Seok Yun
    Kang, Jung Hun
    CANCER COMMUNICATIONS, 2018, 38
  • [6] Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Se Jun Park
    Hyunho Kim
    Kabsoo Shin
    Myung Ah Lee
    Tae Ho Hong
    World Journal of Gastrointestinal Oncology, 2019, (11) : 1021 - 1030
  • [7] Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: A phase II study.
    Van Laethem, JL
    Polus, M
    Marechal, R
    Demols, A
    Gay, F
    Marijken, M
    Hendlisz, A
    Peeters, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 343S - 343S
  • [8] Efficiency of gemcitabine and capecitabine in the treatment of advanced pancreatic cancer
    Zeynalov, R.
    Musayev, I
    Giyasbeyli, S.
    Gasanzadeh, J.
    Dadashova, N.
    Ahadova, N.
    ANNALS OF ONCOLOGY, 2007, 18 : VII117 - VII117
  • [9] Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
    Tschoep-Lechner, Katharina Elisabeth
    Milani, Valeria
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf-Dieter
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2013, 29 (01) : 8 - 16
  • [10] GEMCITABINE AND CISPLATIN COMBINED WITH REGIONAL HYPERTHERMIA AS SECOND-LINE TREATMENT IN PATIENTS WITH GEMCITABINE-REFRACTORY ADVANCED PANCREATIC CANCER
    Lechner, Katharina
    Berger, Frank
    Dieterle, Nelli
    Abdel-Rahman, Sultan
    Salat, Christoph
    Issels, Rolf
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
12345